Evidence map›Paper›PMID 39699248›Full record

ArticleMicrobiology spectrum2025

Effect of colistin-tigecycline combination on colistin-resistant and carbapenem-resistant

Suyeon Park, Yanhong Jin, Kwan Soo Ko

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2026
    Article
  2. Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2025
    Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Suyeon Park *Department of Microbiology, Sungkyunkwan University School of Medicine, Suwon, South Korea.
Yanhong Jin *Department of Microbiology, Sungkyunkwan University School of Medicine, Suwon, South Korea.
Kwan Soo KoDepartment of Microbiology, Sungkyunkwan University School of Medicine, Suwon, South Korea.ORCID 0000-0002-0978-1937

Funding

National Research Foundation of Korea (NRF) NRF-2022R1A2B502001716
6 · The paper itself

Abstract

There is a critical need for treatment strategies to combat carbapenem-resistant Gram-negative pathogens. This study investigates the efficacy of combining low concentrations of colistin with tigecycline against colistin- and carbapenem-resistant IMPORTANCE: Colistin resistance in carbapenem-resistant Gram-negative pathogens is a serious challenge in clinical settings. Our study showed that low concentration of colistin can be effective when combined with tigecycline. It presents the possibility of an available treatment option for antibiotic-resistant pathogens.

Indexed as

Acinetobacter baumanniiAnti-Bacterial AgentsColistinKlebsiella pneumoniaeTigecyclineAcinetobacter InfectionsAnimalsCarbapenemsDrug Resistance, Multiple, BacterialHumansKlebsiella InfectionsLarvaMicrobial Sensitivity TestsMothsAnti-Bacterial AgentsCarbapenemsColistinTigecyclineAcinetobacter baumanniicarbapenem resistancecolistinKlebsiella pneumoniaetigecycline

Identifiers

PMID39699248
PMCPMC11792479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.